Fundz

Newcells Biotech secured £1.2 million in a funding round led by Mercia Ventures to build its customer base and seek new partnerships.

RECENTLY ACQUIREDDec 06, 2024

Amount Raised

£1.2 Million

Round Type

Seed

Newcastle DrawdockBiotechnologyMedicalPharmaceutical

Investors

Northstar VenturesNorth East FinanceMercia Ventures

Description

Newcells Biotech has raised £1.2 million from existing investors including Mercia Ventures, NorthStar Ventures, and North East Finance. The funding will be used to enhance its offering by building its customer base and seeking new partnerships.

Quick answer

Newcells Biotech raised £1.2 Million in a Seed round, dated December 6, 2024. Investors: Northstar Ventures, North East Finance and Mercia Ventures. Newcells Biotech is based in Newcastle Drawdock, England, United Kingdom.

How much did Newcells Biotech raise?
Newcells Biotech raised £1.2 Million in a Seed round on December 6, 2024.
Who invested in Newcells Biotech?
Northstar Ventures, North East Finance and Mercia Ventures are named as investors in this round.
What does Newcells Biotech do?
Newcells Biotech is a Newcastle, London, UK-based company specializing in 3D models that mimic processes within the body and are used by pharmaceutical companies worldwide to test the impact of their drugs, including..
Where is Newcells Biotech based and how big is it?
Newcells Biotech is based in Newcastle Drawdock, England, United Kingdom.
Who are the decision-makers at Newcells Biotech?
Fundz holds 2 contacts at Newcells Biotech. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Pharmaceutical around the same time

Companies in the same sectors as Newcells Biotech that raised within 45 days of this round, from Fundz verified event records.

  • Lipella Pharmaceuticals raised $2.6M (Seed) on December 23, 2024.
  • BioSapien raised $5.5M (Series A) on December 13, 2024.
  • Qnovia raised $14M on October 29, 2024.
  • Convergence Medical raised $5M (Series A) on January 16, 2025.
  • ErlySign raised $1.8M (Pre-Series A) on January 16, 2025.
  • GT Medical Technologies raised $37M (Series D) on January 16, 2025.

Who to call at Newcells Biotech, and when

A new round usually means Newcells Biotech is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Newcells Biotech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Newcells Biotech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Newcells Biotech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Newcells Biotech

Location

Newcastle Drawdock, England, United Kingdom

About

Newcells Biotech is a Newcastle, London, UK-based company specializing in 3D models that mimic processes within the body and are used by pharmaceutical companies worldwide to test the impact of their drugs, including their efficacy and safety. The company offers models of the retina, kidney, and lung, and provides specialist services to run customized tests.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Newcells Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Newcells Biotech's next move

See what Strategic adds

Newcells Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.